Plasmin-dependent elimination of the growth-factor-like domain in urokinase causes its rapid cellular uptake and degradation.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Biochemical Journal

• Publication date

  2001-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1042/BJ3550639PMID 11311125PMCID PMC1221778
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RACK1, A multifaceted scaffolding protein: Structure and function

  2011cited by this paper
• The Chemotactic Action of Urokinase on Smooth Muscle Cells Is Dependent on Its Kringle Domain

  2000cited by this paper
• Urokinase activates calcium-dependent potassium channels in U937 cells via calcium release from intracellular stores.

  1999cited by this paper
• Urokinase-type plasminogen activator induces tyrosine phosphorylation of a 78-kDa protein in H-157 cells.

  1999cited by this paper
• Urokinase Receptor Interacts with αvβ5 Vitronectin Receptor, Promoting Urokinase-dependent Cell Migration in Breast Cancer

  1999cited by this paper
• Urokinase activates the Jak/Stat signal transduction pathway in human vascular endothelial cells.

  1999cited by this paper
• Characterization of cell-associated plasminogen activation catalyzed by urokinase-type plasminogen activator, but independent of urokinase receptor (uPAR, CD87).

  1999cited by this paper
• Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer.

  1999cited by this paper
• Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction.

  1999cited by this paper
• Chemotactic effect of urokinase plasminogen activator: a major role for mechanisms independent of its proteolytic or growth factor domains.

  1999cited by this paper
• FGF‐2 stimulates migration of Kaposi's sarcoma‐like vascular cells by HGF‐dependent relocalization of the urokinase receptor

  1998cited by this paper
• Urokinase receptor-dependent upregulation of smooth muscle cell adhesion to vitronectin by urokinase.

  1998cited by this paper
• Vascular development and disorders: molecular analysis and pathogenic insights.

  1998cited by this paper
• Urokinase Receptor (CD87) Regulates Leukocyte Recruitment via β2 Integrins In Vivo

  1998cited by this paper
• The urokinase receptor

  1998cited by this paper
• Binding of Urokinase-type Plasminogen Activator to Its Receptor in MCF-7 Cells Activates Extracellular Signal-regulated Kinase 1 and 2 Which Is Required for Increased Cellular Motility*

  1998cited by this paper
• TGF-beta signal transduction.

  1998cited by this paper
• Urokinase-Type Plasminogen Activator Receptors Associate with β1 and β3 Integrins of Fibrosarcoma Cells: Dependence on Extracellular Matrix Components

  1997cited by this paper
• Proximity oscillations of complement type 4 (alphaX beta2) and urokinase receptors on migrating neutrophils.

  1997cited by this paper
• Urokinase-type plasminogen activator receptors associate with beta1 and beta3 integrins of fibrosarcoma cells: dependence on extracellular matrix components.

  1997cited by this paper
• The urokinase‐type plasminogen activator system in cancer metastasis: A review

  1997cited by this paper
• Plasminogen activator inhibitor type-2 (PAI-2) in human keratinocytes regulates pericellular urokinase-type plasminogen activator.

  1996cited by this paper
• REGULATION AND ROLE OF UROKINASE PLASMINOGEN ACTIVATOR IN VASCULAR REMODELLING

  1996cited by this paper
• Single-chain urokinase-type plasminogen activator bound to its receptor is relatively resistant to plasminogen activator inhibitor type 1.

  1996cited by this paper
• Inhibitory Effect of a Conjugate between Human Urokinase and Urinary Trypsin Inhibitor on Tumor Cell Invasion in Vitro(*)

  1995cited by this paper
• The Very Low Density Lipoprotein Receptor Mediates the Cellular Catabolism of Lipoprotein Lipase and Urokinase-Plasminogen Activator Inhibitor Type I Complexes (*)

  1995cited by this paper
• The structure and function of the urokinase receptor, a membrane protein governing plasminogen activation on the cell surface.

  1995cited by this paper
• Migrating vascular smooth muscle cells polarize cell surface urokinase receptors after injury in vitro.

  1995cited by this paper
• Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor.

  1994cited by this paper
• Urokinase

  1994cited by this paper
• The receptor for urokinase-type plasminogen activator is expressed by keratinocytes at the leading edge during re-epithelialization of mouse skin wounds.

  1994cited by this paper
• [LDL-receptor-related protein].

  1994cited by this paper
• Differential inhibition of soluble and cell surface receptor-bound single-chain urokinase by plasminogen activator inhibitor type 2. A potential regulatory mechanism.

  1994cited by this paper
• Urokinase-urokinase receptor interaction: non-mitogenic signal transduction in human epidermal cells.

  1993cited by this paper
• Persistence of plasmin‐mediated pro‐urokinase activation on the surface of human monocytoid leukemia cells In Vitro

  1993cited by this paper
• LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation.

  1992cited by this paper
• Purified alpha 2-macroglobulin receptor/LDL receptor-related protein binds urokinase.plasminogen activator inhibitor type-1 complex. Evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes.

  1992cited by this paper
• Importance of plasminogen activator inhibitor type 1 (PAI-1) for preventing single chain urokinase plasminogen activator (scu-PA) conversion into two chain urokinase plasminogen activator (tcu-PA) in plasma in vitro.

  1991cited by this paper
• Plasminogen Activation by Receptor-Bound Urokinase

  1991cited by this paper
• Receptor‐mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI‐1.

  1990cited by this paper
• Lysosomal degradation of receptor-bound urokinase-type plasminogen activator is enhanced by its inhibitors in human trophoblastic choriocarcinoma cells.

  1990cited by this paper
• Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes.

  1989cited by this paper
• Functional characteristics of receptor-bound urokinase on human monocytes: catalytic efficiency and susceptibility to inactivation by plasminogen activator inhibitors.

  1989cited by this paper
• Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants

  1989cited by this paper
• One-chain urokinase-type plasminogen activator from human sarcoma cells is a proenzyme with little or no intrinsic activity.

  1988cited by this paper
• Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells

  1987cited by this paper
• Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors

  1987cited by this paper
• Purification and characterization of single-chain urokinase-type plasminogen activator from human cell cultures.

  1986cited by this paper
• Purification and characterization of a novel low molecular weight form of single-chain urokinase-type plasminogen activator.

  1986cited by this paper
• Proteolytic cleavage of single-chain pro-urokinase induces conformational change which follows activation of the zymogen and reduction of its high affinity for fibrin.

  1985cited by this paper
• Purification of human fibroblast urokinase proenzyme and analysis of its regulation by proteases and protease nexin.

  1984cited by this paper

• Role of Fibrinolytic Enzymes in Anti-Thrombosis Therapy

  2021cites this paper
• Urokinase Plasminogen Activator: A Potential Thrombolytic Agent for Ischaemic Stroke

  2019cites this paper
• Transforming growth factor‐β, matrix metalloproteinases, and urokinase‐type plasminogen activator interaction in the cancer epithelial to mesenchymal transition

  2018influential citation
• Novel patents and cancer therapies for transforming growth factor-beta and urokinase type plasminogen activator: potential use of their interplay in tumorigenesis.

  2014cites this paper
• Studies into the interaction between the plasminogen activating system and the blood-brain barrier

  2013cites this paper
• Fibulin-5 binds urokinase-type plasminogen activator and mediates urokinase-stimulated β1-integrin-dependent cell migration.

  2012cites this paper
• Urokinase-Rezeptor (uPAR) und Zellkontakte : Mechanismen uPAR-abhängiger Zelladhäsion, Zellmigration und Signaltransduktion

  2011cites this paper
• Can inactivators of plasminogen activator inhibitor alleviate the burden of obesity and diabetes? (Review).

  2011cites this paper
• Regulation of arterial remodeling and angiogenesis by urokinase-type plasminogen activator.

  2009cites this paper
• Nuclear translocation of urokinase-type plasminogen activator.

  2008cites this paper
• Mathematical Modelling of Proteolysis and Cancer Cell Invasion of Tissue

  2006cites this paper
• Structural basis of interaction between urokinase-type plasminogen activator and its receptor.

  2006cites this paper
• Production and purification of urokinase: a comprehensive review.

  2006cites this paper
• The kringle domain of urokinase-type plasminogen activator potentiates LPS-induced neutrophil activation through interaction with {alpha}V{beta}3 integrins.

  2005cites this paper
• The kringle domain of urokinase‐type plasminogen activator potentiates LPS‐induced neutrophil activation through interaction with αVβ3 integrins

  2005cites this paper
• Mitogenic signaling of urokinase receptor-deficient kidney fibroblasts: actions of an alternative urokinase receptor and LDL receptor-related protein.

  2004cites this paper
• Urokinase as a Multidomain Protein and Polyfunctional Cell Regulator

  2004cites this paper
• Activation of p38 MAP-Kinase and Caldesmon Phosphorylation Are Essential for Urokinase-Induced Human Smooth Muscle Cell Migration

  2002cites this paper
• Review Article Transforming Growth Factor-beta and Urokinase-type Plasminogen Activator: Dangerous Partners in Tumorigenesis—implications in Skin Cancer

  year unknowncites this paper
• Nuclear Translocation of Urokinase-type Plasminogen Activator Lentivirus-based Nucleolin Rna Interference

  year unknowncites this paper